Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans

Viachaslau Barodka, Edward Acheampong, Garry Powell, Ludmila Lobach, David A. Logan, Zahida Parveen, Valerie Armstead, Muhammad Mukhtar

Research output: Contribution to journalArticle

Abstract

Candida albicans is a dimorphic fungus that can grow in yeast morphology or hyphal form depending on the surrounding environment. This ubiquitous fungus is present in skin and mucus membranes as a potential pathogen that under opportunistic conditions causes a series of systemic and superficial infections known as candidiasis, moniliasis or simply candidiasis. There has been a steady increase in the prevalence of candidiasis that is expressed in more virulent forms of infection. Although candidiasis is commonly manifested as mucocutaneous disease, life-threatening systemic invasion by this fungus can occur in every part of the body. The severity of candidal infections is associated with its morphological shift such that the hyphal morphology of the fungus is most invasive. Of importance, aberrant multiplication of Candida yeast is also associated with the pathogenesis of certain mucosal diseases. In this study, we assessed the anti-candidal activity of the volatile anesthetic isoflurane in liquid form in comparison with the anti-fungal agent amphotericin B in an in vitro culture system. Exposure of C. albicans to isoflurane (0.3% volume/volume and above) inhibited multiplication of yeast as well as formation of hyphae. These data suggest development of potential topical application of isoflurane for controlling a series of cutaneous and genital infections associated with this fungus. Elucidiation of the mechanism by which isoflurane effects fungal growth could offer therapeutic potential for certain systemic fungal infections.

Original languageEnglish (US)
Article number46
JournalJournal of Translational Medicine
Volume4
DOIs
StatePublished - Nov 9 2006
Externally publishedYes

Fingerprint

Candida
Candidiasis
Isoflurane
Fungi
Candida albicans
Anesthetics
Yeast
Liquids
Yeasts
Infection
Antifungal agents
Skin
Hyphae
Mycoses
Amphotericin B
Pathogens
Mucus
Human Body
Membranes
Growth

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Barodka, V., Acheampong, E., Powell, G., Lobach, L., Logan, D. A., Parveen, Z., ... Mukhtar, M. (2006). Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans. Journal of Translational Medicine, 4, [46]. https://doi.org/10.1186/1479-5876-4-46

Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans. / Barodka, Viachaslau; Acheampong, Edward; Powell, Garry; Lobach, Ludmila; Logan, David A.; Parveen, Zahida; Armstead, Valerie; Mukhtar, Muhammad.

In: Journal of Translational Medicine, Vol. 4, 46, 09.11.2006.

Research output: Contribution to journalArticle

Barodka, V, Acheampong, E, Powell, G, Lobach, L, Logan, DA, Parveen, Z, Armstead, V & Mukhtar, M 2006, 'Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans', Journal of Translational Medicine, vol. 4, 46. https://doi.org/10.1186/1479-5876-4-46
Barodka, Viachaslau ; Acheampong, Edward ; Powell, Garry ; Lobach, Ludmila ; Logan, David A. ; Parveen, Zahida ; Armstead, Valerie ; Mukhtar, Muhammad. / Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans. In: Journal of Translational Medicine. 2006 ; Vol. 4.
@article{9b26100d85e64ba7a13f5288c7f5f543,
title = "Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans",
abstract = "Candida albicans is a dimorphic fungus that can grow in yeast morphology or hyphal form depending on the surrounding environment. This ubiquitous fungus is present in skin and mucus membranes as a potential pathogen that under opportunistic conditions causes a series of systemic and superficial infections known as candidiasis, moniliasis or simply candidiasis. There has been a steady increase in the prevalence of candidiasis that is expressed in more virulent forms of infection. Although candidiasis is commonly manifested as mucocutaneous disease, life-threatening systemic invasion by this fungus can occur in every part of the body. The severity of candidal infections is associated with its morphological shift such that the hyphal morphology of the fungus is most invasive. Of importance, aberrant multiplication of Candida yeast is also associated with the pathogenesis of certain mucosal diseases. In this study, we assessed the anti-candidal activity of the volatile anesthetic isoflurane in liquid form in comparison with the anti-fungal agent amphotericin B in an in vitro culture system. Exposure of C. albicans to isoflurane (0.3{\%} volume/volume and above) inhibited multiplication of yeast as well as formation of hyphae. These data suggest development of potential topical application of isoflurane for controlling a series of cutaneous and genital infections associated with this fungus. Elucidiation of the mechanism by which isoflurane effects fungal growth could offer therapeutic potential for certain systemic fungal infections.",
author = "Viachaslau Barodka and Edward Acheampong and Garry Powell and Ludmila Lobach and Logan, {David A.} and Zahida Parveen and Valerie Armstead and Muhammad Mukhtar",
year = "2006",
month = "11",
day = "9",
doi = "10.1186/1479-5876-4-46",
language = "English (US)",
volume = "4",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans

AU - Barodka, Viachaslau

AU - Acheampong, Edward

AU - Powell, Garry

AU - Lobach, Ludmila

AU - Logan, David A.

AU - Parveen, Zahida

AU - Armstead, Valerie

AU - Mukhtar, Muhammad

PY - 2006/11/9

Y1 - 2006/11/9

N2 - Candida albicans is a dimorphic fungus that can grow in yeast morphology or hyphal form depending on the surrounding environment. This ubiquitous fungus is present in skin and mucus membranes as a potential pathogen that under opportunistic conditions causes a series of systemic and superficial infections known as candidiasis, moniliasis or simply candidiasis. There has been a steady increase in the prevalence of candidiasis that is expressed in more virulent forms of infection. Although candidiasis is commonly manifested as mucocutaneous disease, life-threatening systemic invasion by this fungus can occur in every part of the body. The severity of candidal infections is associated with its morphological shift such that the hyphal morphology of the fungus is most invasive. Of importance, aberrant multiplication of Candida yeast is also associated with the pathogenesis of certain mucosal diseases. In this study, we assessed the anti-candidal activity of the volatile anesthetic isoflurane in liquid form in comparison with the anti-fungal agent amphotericin B in an in vitro culture system. Exposure of C. albicans to isoflurane (0.3% volume/volume and above) inhibited multiplication of yeast as well as formation of hyphae. These data suggest development of potential topical application of isoflurane for controlling a series of cutaneous and genital infections associated with this fungus. Elucidiation of the mechanism by which isoflurane effects fungal growth could offer therapeutic potential for certain systemic fungal infections.

AB - Candida albicans is a dimorphic fungus that can grow in yeast morphology or hyphal form depending on the surrounding environment. This ubiquitous fungus is present in skin and mucus membranes as a potential pathogen that under opportunistic conditions causes a series of systemic and superficial infections known as candidiasis, moniliasis or simply candidiasis. There has been a steady increase in the prevalence of candidiasis that is expressed in more virulent forms of infection. Although candidiasis is commonly manifested as mucocutaneous disease, life-threatening systemic invasion by this fungus can occur in every part of the body. The severity of candidal infections is associated with its morphological shift such that the hyphal morphology of the fungus is most invasive. Of importance, aberrant multiplication of Candida yeast is also associated with the pathogenesis of certain mucosal diseases. In this study, we assessed the anti-candidal activity of the volatile anesthetic isoflurane in liquid form in comparison with the anti-fungal agent amphotericin B in an in vitro culture system. Exposure of C. albicans to isoflurane (0.3% volume/volume and above) inhibited multiplication of yeast as well as formation of hyphae. These data suggest development of potential topical application of isoflurane for controlling a series of cutaneous and genital infections associated with this fungus. Elucidiation of the mechanism by which isoflurane effects fungal growth could offer therapeutic potential for certain systemic fungal infections.

UR - http://www.scopus.com/inward/record.url?scp=33845702483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845702483&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-4-46

DO - 10.1186/1479-5876-4-46

M3 - Article

VL - 4

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

M1 - 46

ER -